Next Article in Journal
Immunomodulatory and Antitumoral Activity of Gold Nanoparticles Synthesized by Red Algae Aqueous Extracts
Previous Article in Journal
Structural and Molecular Characterization of Squalene Synthase Belonging to the Marine Thraustochytrid Species Aurantiochytrium limacinum Using Bioinformatics Approach
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 20
Issue 3
10.3390/md20030181
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Fucoidan (Undaria pinnatifida)/Polydopamine Composite-Modified Surface Promotes Osteogenic Potential of Periodontal Ligament Stem Cells

by
Kyu Hwan Kwack
1,
Ju Young Ji
2,
Borami Park
2 and
Jung Sun Heo
2,*
1
Department of Oral Biology, School of Dental Medicine, University at Buffalo, State University of New York, New York, NY 14214, USA
2
Department of Maxillofacial Biomedical Engineering, Institute of Oral Biology, School of Dentistry, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 02447, Korea
*
Author to whom correspondence should be addressed.
Mar. Drugs 2022, 20(3), 181; https://doi.org/10.3390/md20030181
Submission received: 11 January 2022 / Revised: 21 February 2022 / Accepted: 24 February 2022 / Published: 28 February 2022
Browse Figures
Review Reports Versions Notes

Abstract

:
Fucoidan, a marine-sulfated polysaccharide derived from brown algae, has been recently spotlighted as a natural biomaterial for use in bone formation and regeneration. Current research explores the osteoinductive and osteoconductive properties of fucoidan-based composites for bone tissue engineering applications. The utility of fucoidan in a bone tissue regeneration environment necessitates a better understanding of how fucoidan regulates osteogenic processes at the molecular level. Therefore, this study designed a fucoidan and polydopamine (PDA) composite-based film for use in a culture platform for periodontal ligament stem cells (PDLSCs) and explored the prominent molecular pathways induced during osteogenic differentiation of PDLSCs through transcriptome profiling. Characterization of the fucoidan/PDA-coated culture polystyrene surface was assessed by scanning electron microscopy and X-ray photoelectron spectroscopy. The osteogenic differentiation of the PDLSCs cultured on the fucoidan/PDA composite was examined through alkaline phosphatase activity, intracellular calcium levels, matrix mineralization assay, and analysis of the mRNA and protein expression of osteogenic markers. RNA sequencing was performed to identify significantly enriched and associated molecular networks. The culture of PDLSCs on the fucoidan/PDA composite demonstrated higher osteogenic potency than that on the control surface. Differentially expressed genes (DEGs) (n = 348) were identified during fucoidan/PDA-induced osteogenic differentiation by RNA sequencing. The signaling pathways enriched in the DEGs include regulation of the actin cytoskeleton and Ras-related protein 1 and phosphatidylinositol signaling. These pathways represent cell adhesion and cytoskeleton organization functions that are significantly involved in the osteogenic process. These results suggest that a fucoidan/PDA composite promotes the osteogenic potential of PDLSCs by activation of critical molecular pathways.

1. Introduction

A variety of biomaterials, such as ceramics, polymers, and nanomaterials, are used to modify the surface properties of bone tissue-implantable devices [1,2,3]. An ideal coating substrate for implantable material must be both biocompatible and implantable and support the recruitment, adhesion, proliferation, and differentiation of cells both in vitro and in vivo. For bone tissue engineering applications, promising osteoconductive biomaterials must recreate a biophysical microenvironment similar to the extracellular matrix (ECM), which regulates the behavior and function of osteogenic-related cells. Thus, the discovery and development of advanced biomaterials that mimic the ECM is a crucial issue in bone regeneration and repair medicine.
The fabrication of surfaces with multiple biological functions has employed polymeric substances, such as proteins [4,5] and polysaccharides [6,7], for biomimetic ECM construction. Many natural polysaccharides have hydrogel properties that can potentially serve as an ECM within moist circumstances [8,9]. One of these natural polysaccharides, fucoidan, a marine-sulfated polysaccharide from the cell wall of brown algae, has been studied due to its anticoagulant [10], antifouling [11], and anti-inflammatory properties [12]. These biological actions of fucoidan can be influenced by its chemical construction with different sulfate and monosaccharide compositions. For instance, a main difference between fucoidan derived from Undaria pinnatifida and that from other brown algae is the monosaccharide formation of polysaccharide molecules [13,14]. Recently, fucoidan has been introduced as a suitable biomaterial for bone tissue regeneration [15,16,17]. Fucoidan from Undaria pinnatifida has been reported to enhance the osteogenic differentiation of human adipose-derived stem cells [18]. Other research suggests that fucoidan from Undaria pinnatifida-supplemented biocomposites can be a potential biomaterial for bone tissue regeneration [19]. Similar to fucoidan from Undaria pinnatifida, MSCs cultured on fucoidan from a Fucus Vesiculosus-containing composite scaffold showed increased mineral deposition [17,20]. Additionally, the functionalized scaffold composed of fucoidan (from Fucus Vesiculosus), a bioactivator in stem cell differentiation and nano-hydroxyapatite (nHA), is an inducing factor in bone mineralization attributed to bone tissue engineering applications [21]. Although the chemical composition of fucoidan differs between brown algae species, the bioactivity of fucoidan can support an osteogenic microenvironment that may ultimately reconstruct bone tissue. However, the precise molecular mechanisms underlying the observed effects of fucoidan within these substrates remain unknown.
Marine-derived polysaccharides have attracted high attention to fabricating functional matrices for biomedical devices and implants. However, these biomaterials cannot accomplish vigorous mechanical properties for hydrogelling [22,23]. Therefore, it is necessary to study which physicochemical conditions can modify and reinforce the rheological properties of natural polysaccharides. Previous studies demonstrated that the introduction of gelatin, a protein derived from collagen, into the alginate, a polysaccharide found in Fucus vesiculosus, increased the yield stress and viscosity of the hydrogels [23]. Corresponding with these issues, the present study employed mussel-inspired polydopamine (PDA), containing catechol and amine groups, to affix fucoidan to surfaces efficiently. Given the strong adhesive property and chemical stability of PDA, it has been utilized for the functional hydrogelling of polysaccharides to coat various substrates [24,25]. A recent study reported that the addition of PDA strengthened hemicellulose hydrogels with high mechanical properties [26]. Moreover, the incorporation of PDA into the dextran hydrogel enhanced the adhesion and drug loading capacity [27]. From a biological point of view, a heparin/PDA-conjugated film provided an effective feeder-free culture system for pluripotent human embryonic stem cells [28]. Data suggest that polysaccharide/PDA coatings can impact osteogenesis. A composite of a natural amino-polysaccharide, carboxymethyl chitosan, and PDA enhanced the osteogenic potential of human pluripotent stem cells in vitro [29]. Furthermore, a chondroitin sulfate/PDA-modified graft strengthened the osteogenic differentiation of MSCs and promoted new bone formation in vivo [30].
Periodontal ligament (PDL), a specialized tissue, anchors tooth to the bone socket in the jaw and manages tooth homeostasis, immune response, and repair [31]. Periodontal ligament stem cells (PDLSCs) are a mesenchymal stem cell (MSCs) population derived from PDL tissue and can differentiate into various types of mesenchymal-lineage cells, including periodontal tissue cells and bone-forming osteoblasts under proper experimental conditions [32,33,34]. A previous clinical pilot study demonstrated the potential competence and safety of autologous PDLSCs in the treatment of periodontal osseous defects [35]. Interestingly, human PDLSCs presented much higher growth capacity than human bone marrow-derived MSCs [36]. In terms of the ease of access of PDLSCs compared to other types of stem cells, PDLSCs are currently suggested as a useful source for stem cell-based approaches for regeneration of not only periodontal tissues but also bone tissues.
The present study herein designed a fucoidan and PDA composite-based hydrogel film for use in culture platforms to test if fucoidan could provide the artificial microenvironments necessary to intensify osteogenic potential using a periodontal ligament stem cells (PDLSCs) model. Additionally, we classify the critical molecular signaling pathways arising from fucoidan/PDA substrate that influence the osteogenic differentiation of PDLSCs. The findings suggest that a fucoidan/PDA composite is a useful strategy for the bio-coating of implantable devices used for bone tissue healing and regeneration.

2. Results

2.1. Fucoidan/PDA-Coated Surface Encourages the Osteogenic Differentiation of PDLSCs

The microstructure morphology of fucoidan/PDA composites was analyzed using SEM images. Distinct from the control surface, the fucoidan/PDA composites displayed a multilayered structure (Figure 1A). The fucoidan/PDA composites were also characterized by XPS to evaluate the surface chemistry. With the functionalization of fucoidan/PDA, carbon amounts decreased while amounts of oxygen, nitrogen, and particularly sulfur from the sulfate groups of fucoidan increased (Figure 1B). Given these results, the fucoidan/PDA composite successfully coated the PT surface.
Subsequently, the osteogenic differentiation of PDLSCs cultured on control and fucoidan/PDA-coated surfaces was evaluated by analyzing ALP activity, intracellular calcium levels ([Ca2+]i), and extracellular calcium deposits. ALP activity within cells on the fucoidan/PDA substrate increased compared to the control group on day 4, with a further increase on day 7 (Figure 1C). Increased [Ca2+]i was also observed in cells on fucoidan/PDA substrates in a fucoidan dose-dependent manner (Figure 1D). Furthermore, extracellular calcium deposits were present with corresponding increases in PDLSCs on the fucoidan/PDA substrate compared with the control groups (Figure 1E).
To further determine the osteogenic effect of the fucoidan/PDA substrate on PDLSCs, the expression of osteogenic markers was assessed at the gene and protein level. The expression of osteogenic target genes, such as runt-related transcription factor 2 (RUNX2), osteopontin (OPN), collagen type I (COLI), osterix (OSX), and osteocalcin (OCN), was increased in cells on a fucoidan/PDA coating compared with the control group. The highest expression of osteogenic target genes was present in cells on 1 µg/mL of fucoidan/PDA (Figure 2A–E). In addition, OCN and RUNX2 protein levels were elevated in cells cultured on the fucoidan/PDA substrate on day 7 of osteogenic induction (Figure 2F). Taken together, these results suggest that the fucoidan/PDA substrate enhances the osteogenic potential of PDLSCs.

2.2. Identification of Differentially Expressed Genes (DEGs)

RNA sequencing was performed with PDLSCs cultured on the fucoidan/PDA substrate for 7 days. Genes displaying a fold-change cut-off of >2 in expression and a p-value < 0.05 were selected as significantly upregulated or downregulated genes in fucoidan/PDA substrate-cultured cells compared to the control group. Using these criteria, 348 DEGs (58 upregulated and 290 downregulated) were identified during fucoidan/PDA substrate-induced osteogenic induction (Supplementary Data S1). Cluster analysis of DEGs showed significant differences between cells cultured on the fucoidan/PDA substrate compared to the control substrate (Figure 3A). To determine the functions of the DEGs, gene ontology (GO) analysis was performed based on biological process and molecular function categories. The top 10 enriched GO terms were ranked. Briefly, Ras protein signal transduction and the phosphatidylinositol-3-phosphate biosynthetic process were significantly enriched in the cells cultured on the fucoidan/PDA substrate (Figure 3B). The GO terms related to molecular function showed that the DEGs were enriched in protein binding and DNA binding (Figure 3C). Validation of RNA-Seq data was performed by real-time RT-PCR with selected genes (EPCAM, NECAB3, HMOX1, PRPF38B, TRIM33, CAMSAP2). These genes were up or downregulated in a similar pattern of RNA-Seq analysis (Figure 3D).

2.3. KEGG Pathway Analysis

To further identify the biologically relevant signaling pathways of DEGs, KEGG pathway enrichment analysis was performed. From the KEGG pathway study, 10 pathways related to the DEGs were identified (Table 1).
Among these pathways, the DEGs were highly associated with biological pathways critical for osteogenic differentiation, including regulation of actin cytoskeleton, Ras-related protein 1 (Rap1) signaling, and phosphatidylinositol signaling (Figure 4, Figure 5 and Figure 6).

2.4. Protein–Protein Interaction (PPI) Network

Lastly, potential DEG interactions at the protein level were profiled using the STRING database to predict PPI networks. A total of 348 potential genes were uploaded to the STRING database to construct potential protein networks of DEGs (Figure 7).
The top hub of proteins with the highest number of PPI showed 11–21 interactions for each individual hub (Figure 8A). The top hubs of proteins include KRAS proto-oncogene, GTPase (KRAS), ATM serine/threonine kinase (ATM), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), RNA-binding motif protein 25 (RBM25), MutS homolog 2 (MSH2), and senataxin (SETX). Interestingly, the KRAS and ATM hub proteins had the highest number of interactions, with 21 proteins partners according to the STRING database (Figure 8B).

3. Discussion

This study finds that the polymeric combination of fucoidan/PDA composites can be an alternative design for biomimetic ECM construction to encourage osteogenic differentiation of PDLSCs. Current studies have shown the potential application of a natural biomaterial, fucoidan, in surface functionalization technology. Fucoidan has been shown to have characteristics useful for antifouling, cancer therapy, and vascular and bone regeneration [11,17,37]. Regarding osteogenic regeneration and bone health, fucoidan facilitates osteogenic-related cell proliferation through increased ALP activity, calcium deposition, and bone morphogenetic protein 2 (BMP2) levels, and it is connected with bone mineralization and development [38,39,40]. Fucoidan-based ceramic or protein-combined scaffolds accelerate osteogenesis and mineralization, which makes it a very promising composite technique in bone tissue engineering [16,41].
Unique from other reports of fucoidan-based composites as bone forming-biomaterials, the present study profiles the changing cellular transcriptome to further unveil molecular and functional pathways encouraged by fucoidan/PDA composites during osteogenic induction. KEGG pathway enrichment analysis revealed that significantly enriched DEGs include the regulation of actin cytoskeleton, the Rap1 signaling pathway, and the phosphatidylinositol signaling system. Effects of the actin cytoskeleton suggest a connection between the cell and the outside environment, which triggers cell-ECM interaction through various intracellular signaling networks [42,43]. The cytoskeleton network may serve to strengthen the osteogenic potential of PDLSCs in response to the fucoidan/PDA composite. Similar studies have reported actin cytoskeleton dynamics are commonly observed when MSCs and other osteogenic cells commit to osteogenic lineages [44,45,46,47]. A better understanding of the cytoskeletal network may provide notable insights into the osteogenic regulation of PDLSCs by fucoidan/PDA.
Interestingly, Rap1, a member of the Ras superfamily of small GTPase, is involved in cell-ECM adhesion and cell–cell junctions through reorganization of the actin cytoskeleton in mammalian cells [48,49]. Several studies have reported that Rap1 signaling promotes the osteogenic differentiation of MSCs and osteoblastic cells, although few data exist that show a role for Rap1 in regulation of osteogenic cell differentiation [50,51,52]. Rap1 may be a crucial marker for the complex network of cell-interface events involved in stem cell differentiation into the osteogenic lineage. As such, the fucoidan/PDA composite performs as an ideal ECM architecture mimic by crucially stimulating the Rap1-actin cytoskeleton network involved in cell adhesion to encourage the osteogenic differentiation of PDLSCs.
KEGG pathway analysis indicated that phosphatidylinositol signaling is a prominent pathway in PDLSCs plated on the fucoidan/PDA composite. Phosphatidylinositol signaling is involved in virtually all cellular functions, including cell proliferation, differentiation, and metabolic processes [53]. Phosphatidylinositol is classified as a glycerophospholipid that anchors to the cytoplasmic face of the cellular membrane. The phosphorylation of phosphatidylinositol leads to activation of the PI3K/Akt pathway, which includes key intracellular molecules in the phosphatidylinositol system involved in principle roles across multiple cellular processes [54]. Furthermore, phosphatidylinositol signaling influences cell adhesion and actin cytoskeleton assembly [55,56] and influences the differentiation of stem cells and osteoblasts and also bone homeostasis [57,58,59]. These data suggest that the actin cytoskeleton network, Rap1 signaling, and phosphatidylinositol signaling may be important mechanisms by which the ECM-like architecture of fucoidan/PDA promotes the osteogenic differentiation of PDLSCs.
Using RNA-Seq results to uncover PPI networks, we found several significant hub proteins. Consistent with KEGG analysis, cell adhesion and cytoskeleton assembly proteins, such as KRAS, a small GTPase, and phosphatidylinositol signaling, were identified as significant hubs. Additionally, the ATM serine/threonine kinase was found as a hub and is involved in focal adhesion and actin cytoskeleton rearrangement in cancer progression [60]. Another hub protein, senataxin, is an RNA/DNA helicase reported to regulate actin cytoskeleton organization for vesicle transport and autophagy regulation [61]. Taken together, this study suggests that the cell adhesion and cytoskeleton assembly events of a fucoidan/PDA substrate impact the differentiation of PDLSCs into osteogenic lineages.
Indeed, the biological activity of fucoidan is considerably influenced by different molecular composition, sulfates position, and the polysaccharide framework. Although it is necessary to perform chemical structure-dependent studies to elucidate the physicochemical properties of fucoidan as a functional ECM biomaterial, regarding the main focus of this study, we engineered a natural polysaccharide, fucoidan (Undaria pinnatifida), and PDA composite for ECM construction to enable PDLSC adhesion and osteogenic differentiation. Additionally, a comprehensive bioinformatic analysis was performed to elucidate the molecular mechanisms underlying fucoidan/PDA-induced PDLSC-osteogenic differentiation. Finally, these findings provide novel insights into molecular targets for the development of implantable devices for periodontal tissue and bone regeneration.

4. Materials and Methods

4.1. Materials

Fetal bovine serum (FBS) and α-MEM were obtained from Gibco-BRL (Gaithersburg, MD, USA). Chemicals, including fucoidan (from Undaria pinnatifida, F8315, ≥95% Purity) and dopamine hydrochloride, and laboratory wares were purchased from the Sigma-Aldrich (St. Louis, MO, USA) and SPL Lifescience (Pocheon, Korea), respectively. Antibodies were supplied by Santa Cruz Biotechnology (Santa Cruz, CA, USA).

4.2. Periodontal Ligament Stem Cell Culture

Human periodontal ligament stem cells were obtained from CELPROGEN (CELPROGEN, Torrance, CA, USA). The culture of PDLSCs was previously described [62]. Cells were cultured on cell culture polystyrene (PT) (control), PDA-coated, or fucoidan/PDA-coated surfaces with an osteogenic medium (α-MEM containing 5% FBS, 50 μg/mL ascorbic acid, 1 μM dexamethasone, and 3 mM β-glycerophosphate).

4.3. Preparation of the Fucoidan/PDA Composite Substrate

The PDA solution was prepared by dissolving 1 mg of L-DOPA in 1 mL of 10 mM Tris buffer base (pH 8.5; Sigma-Aldrich). Fucoidan was added to the PDA solution (1 mg/mL), and the mixture was stirred at room temperature for 24 h. The final concentration of fucoidan in the PDA solution was 0.5 or 1 µg/mL for each experiment. The PT culture surface was layered with a fucoidan/PDA composite solution overnight at room temperature and washed three times with sterile phosphate-buffered saline (PBS). Fucoidan/PDA-coated surfaces were then dried in a vacuum oven.

4.4. Characterization of the Fucoidan/PDA-Coated Surface

Each specimen was rinsed with PBS and freeze-dried overnight. Then the surface images of the fucoidan/PDA composite were assessed using scanning electron microscopy (SEM; S-4700, Hitachi, Schaumburg, IL, USA). X-ray photoelectron spectroscopy (XPS) was performed to evaluate the atomic composition of the fucoidan/PDA-modified surfaces as described in our previous study [62,63]. The surface composition concentration was acquired from the XPS survey spectra.

4.5. Alkaline Phosphatase (ALP) Activity

ALP activity was evaluated as described in our previous study [62,63]. Briefly, cells were lysed, total protein concentration was determined, 200 μL of p-nitrophenylphosphate (pNPP) were added to the cell lysate, and the mixture was incubated for 30 min at 37 °C. The reaction was then stopped by adding of 3 M NaOH. The standard curve was prepared using a p-nitrophenol solution (10 mM, Sigma-Aldrich), and each of the standards with p-nitrophenol concentrations was formulated between 0.2 and 100 μM. Absorbance of each sample and standard was measured with a microplate spectrophotometer (MicroDigital Co., Ltd., Seongnam, Korea) at 405 nm. The mean absorbance of the blank standard was subtracted from all standard and sample readings. The ALP activity was calculated from the linear regression equation obtained from the standard curve using Microsoft Excel. ALP activity was presented as μM/100 μg of protein.

4.6. Intracellular Calcium Quantification Assay

Intracellular calcium content was determined as described in our previous report [62,63]. Briefly, cells were cultured onto fucoidan/PDA composite-coated surfaces. Seven and fourteen days after osteogenic induction, the intracellular calcium level was quantified using a calcium assay kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer’s instructions. Standard solution (0~6 mg/dl) was prepared and read optical density with a microplate spectrophotometer at 612 nm. The absorbance of blank standard was subtracted from all standard and sample absorbance values. Calcium concentration of the sample was calculated from the linear regression equation obtained from standard curve. Calcium levels were converted as mg/100 mg of protein.

4.7. Alizarin Red S Staining

Alizarin Red S staining was performed to identify calcium deposits in cell cultures as described in our previous report [62,63]. Cells were fixed with 4% paraformaldehyde for 15 min after a 14-day osteogenic incubation. Cells were then rinsed three times with PBS and stained with 2% alizarin red S solution (pH 4.2) for 5 min. Stained cells were rinsed three times and observed with a light microscope (Olympus DP72, Tokyo, Japan).

4.8. RNA Extraction and Real-Time Reverse Transcriptase–Polymerase Chain Reaction (RT-PCR)

RNA extraction, cDNA synthesis, and real-time RT-PCR procedures were performed as previously described using a QuantiTect SYBR Green PCR kit (Qiagen) and icycler iQ Multi-color Real-time RT-PCR System [27]. The reaction conditions were 95 °C for 30 s, 95 °C for 5 s, 55 °C for 30 s, and 72 °C for 30 s for 40 cycles. The primers for osteogenic-related genes were as follows: 5′- GTCTCACTGCCTCTCACTTG-3′ (sense) and 5′-CACACATCTCCTCCCTTCTG-3′ (antisense) for RUNX2; 5′-GCAGACCTGACATCCAGTACC-3′ (sense) and 5′-GATGGCCTTGTATGCACCTTC-3′ (antisense) for OPN; 5′-GCGGCTCCCCATTTTTATACC-3′ (sense) and 5′-GCTCTCCTCCCATGTTAAATAGCAC-3′ (antisense) for COL I; 5′- ATGAGAGCCCTCACACTCTCG-3′ (sense) and 5′- GTCAGCCAACTCGTCACAGTCC-3′ (antisense) for OCN; 5′-TGAGGAGGAAGTTCACTATGG-3′ (sense) and 5′-TTCTTTGTGCCTGCTTTGC-3′ (antisense) for OSX; 5′-GCCAGTGTACTTCAGTTGGTGC-3′ (sense) and 5′-CCCTTCAGGTTTTGCTCTTCTCC (antisense) for EPCAM; 5′-GCATTGGAATCGCTGAACCGTG-3′ (sense) and 5′-CGCGTCACAAACTGGTCCACTT-3′ (antisense) for NECAB3; 5′-CCAGGCAGAGAATGCTGAGTTC-3′ (sense) and 5′- AAGACTGGGCTCTCCTTGTTGC-3′ (antisense) for HMOX1; 5′-CCAACATCCTGTCGTCGCCTTA-3′ (sense) and 5′-CCCGCTGTTTTCCTGCTTCCTT-3′ (antisense) for PRPF38B; 5′-CCTCAGTTACCAATCCAGAAAACC-3′ (sense) and 5′- GGTAGGTGACTGCCTGAGATGT-3′ (antisense) for TRIM33; 5′-GGAGGTCAAAAGGCTCGTTATCG-3′ (sense) and 5′- GGCAGCTAATGCACAGCCATCT-3′ (antisense) for CAMSAP2; and 5′- GCTCTCCAGAACATCATCC-3′ (sense) and 5′-TGCTTCACCACCTTCTTG-3′ (antisense) for GAPDH.

4.9. Western Blot Analysis

Total protein extraction and SDS-polyacrylamide gel electrophoresis were performed as previously described [34]. Primary (anti-OCN, anti-RUNX2, or anti-β-actin; Santa Cruz Biotechnology) and secondary antibodies (goat anti-rabbit immunoglobulin G (IgG) or goat anti-mouse IgG conjugated to horseradish peroxidase) were used to identify the osteogenic differentiation of PDLSCs.

4.10. Library Preparation and Sequencing

RNA sequencing was performed as described previously [64]. In brief, total RNA was extracted, and the library was constructed using a QuantSeq 3′ mRNA-Seq Library Prep Kit (Lexogen, Inc., Vienna, Austria) according to the manufacturer’s instructions. The library was amplified to add the complete adapter sequences required for cluster production. The completed library was purified from PCR components, and high-throughput sequencing was then achieved as single-end 75 sequencing using NextSeq 500 (Illumina, Inc., San Diego, CA, USA).

4.11. Data Analysis

QuantSeq 3′ mRNA-Seq reads were aligned using Bowtie2 [65]. Bowtie2 indices were generated from either the genome assembly sequence or the representative transcript sequences for aligning to the genome and transcriptome. The alignment file was applied for assembling transcripts and assessing the amounts and differential expression. Differentially expressed genes (DEGs) were evaluated based on counts from unique and multiple alignments using coverage in Bedtools [66]. The RC (Read Count) data were acquired from the quantile normalization method using EdgeR within R by Bioconductor [67]. Gene classification and ontology were searched using DAVID (http://david.abcc.ncifcrf.gov/, accessed on 27 August 2021.) and Medline databases (http://www.ncbi.nlm.nih.gov/, accessed on 27 August 2021). Data mining and graphic visualization were performed using ExDEGA (Ebiogen Inc., Seoul, Korea). The construction of the target protein–protein interaction (PPI) network was performed for protein targets using STRING v3.8.2. A PPI score of >0.4 (p < 0.05) was considered significant. The PPI networks were visualized using Cytoscape software (http://www.cytoscape.org, accessed on 15 September 2021).

4.12. Statistical Analysis

Data are expressed as means ± standard deviation using SPSS software (ver. 10.0; SPSS Inc., Chicago, IL, USA). One-way analysis of variance was applied for multiple comparisons (Duncan’s multiple range test). A p value < 0.05 was considered a statistically significant difference.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md20030181/s1, Data S1: 348 DEGs (58 upregulated and 290 downregulated).

Author Contributions

Conceptualization, J.S.H. and K.H.K.; Methodology and investigation, J.Y.J. and B.P.; Data curation, J.S.H., K.H.K. and J.Y.J.; Writing—original draft preparation, J.S.H. and K.H.K.; Visualization, J.Y.J. and B.P.; Supervision, J.S.H.; Project administration, J.S.H.; Funding acquisition, J.S.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2018R1D1A1B07047538; 2021R1A2C1014077).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Incesu, E.; Yanikoglu, N. Evaluation of the effect of different polishing systems on the surface roughness of dental ceramics. J. Prosthet. Dent. 2020, 124, 100–109. [Google Scholar] [CrossRef] [PubMed]
  2. Oladapo, B.I.; Ismail, S.O.; Bowoto, O.K.; Omigbodun, F.T.; Olawumi, M.A.; Muhammad, M.A. Lattice design and 3D-printing of PEEK with Ca10(OH)(PO4)3 and in-vitro bio-composite for bone implant. Int. J. Biol. Macromol. 2020, 165, 50–62. [Google Scholar] [CrossRef] [PubMed]
  3. Min, J.; Choi, K.Y.; Dreaden, E.; Padera, R.F.; Braatz, R.D.; Spector, M.; Hammond, P.T. Designer Dual Therapy Nanolayered Implant Coatings Eradicate Biofilms and Accelerate Bone Tissue Repair. ACS Nano 2016, 10, 4441–4450. [Google Scholar] [CrossRef] [PubMed]
  4. Li, G.; Yang, P.; Qin, W.; Maitz, M.; Zhou, S.; Huang, N. The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization. Biomaterials 2011, 32, 4691–4703. [Google Scholar] [CrossRef]
  5. Wang, X.; Yan, C.; Ye, K.; He, Y.; Li, Z.; Ding, J. Effect of RGD nanospacing on differentiation of stem cells. Biomaterials 2013, 34, 2865–2874. [Google Scholar] [CrossRef]
  6. Li, J.; Zhang, K.; Xu, Y.; Chen, J.; Yang, P.; Zhao, Y.; Zhao, A.; Huang, N. A novel coculture model of HUVECs and HUASMCs by hyaluronic acid micropattern on titanium surface. J. Biomed. Mater. Res. Part A 2014, 102, 1950–1960. [Google Scholar] [CrossRef]
  7. Yang, Z.; Tu, Q.; Wang, J.; Huang, N. The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 2012, 33, 6615–6625. [Google Scholar] [CrossRef]
  8. Jeon, O.; Powell, C.; Solorio, L.D.; Krebs, M.D.; Alsberg, E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J. Control. Release 2011, 154, 258–266. [Google Scholar] [CrossRef] [Green Version]
  9. Ying, H.; Zhou, J.; Wang, M.; Su, D.; Ma, Q.; Lv, G.; Chen, J. In situ formed collagen-hyaluronic acid hydrogel as biomimetic dressing for promoting spontaneous wound healing. Mater. Sci. Eng. C 2019, 101, 487–498. [Google Scholar] [CrossRef]
  10. Wang, J.; Zhang, Q.; Zhang, Z.; Song, H.; Li, P. Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica. Int. J. Biol. Macromol. 2010, 46, 6–12. [Google Scholar] [CrossRef]
  11. Jeong, Y.; Thuy, L.T.; Ki, S.H.; Ko, S.; Kim, S.; Cho, W.K.; Choi, J.S.; Kang, S.M. Multipurpose Antifouling Coating of Solid Surfaces with the Marine-Derived Polymer Fucoidan. Macromol. Biosci. 2018, 18, e1800137. [Google Scholar] [CrossRef]
  12. Tian, T.; Chang, H.; He, K.; Ni, Y.; Li, C.; Hou, M.; Chen, L.; Xu, Z.; Chen, B.; Ji, M. Fucoidan from seaweed Fucus vesiculosus inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis. Int. Immunopharmacol. 2019, 75, 105823. [Google Scholar] [CrossRef]
  13. Vishchuk, O.S.; Ermakova, S.P.; Zvyagintseva, T.N. Sulfated polysaccharides from brown seaweeds Saccharina japonica and Undaria pinnatifida: Isolation, structural characteristics, and antitumor activity. Carbohydr. Res. 2011, 346, 2769–2776. [Google Scholar] [CrossRef]
  14. Kalimuthu, S.; Kim, S.K. Fucoidan, A Sulfated Polysaccharides from Brown Algae as Therapeutic Target for Cancer; Springer International Publishing: Cham, Switzerland, 2015; pp. 145–164. ISBN 978-3-319-07144-2. [Google Scholar]
  15. Pajovich, H.T.; Banerjee, I.A. Biomineralization of Fucoidan-Peptide Blends and Their Potential Applications in Bone Tissue Regeneration. J. Funct. Biomater. 2017, 8, 41. [Google Scholar] [CrossRef] [Green Version]
  16. Kim, B.S.; Kang, H.J.; Park, J.Y.; Lee, J. Fucoidan promotes osteoblast differentiation via JNK-and ERK-dependent BMP2–Smad 1/5/8 signaling in human mesenchymal stem cells. Exp. Mol. Med. 2015, 47, e128. [Google Scholar] [CrossRef]
  17. Ohmes, J.; Xiao, Y.; Wang, F.; Mikkelsen, M.D.; Nguyen, T.T.; Schmidt, H.; Seekamp, A.; Meyer, A.S.; Fuchs, S. Effect of Enzymatically Extracted Fucoidans on Angiogenesis and Osteogenesis in Primary Cell Culture Systems Mimicking Bone Tissue Environment. Mar. Drugs 2020, 18, 481. [Google Scholar] [CrossRef]
  18. Park, S.-J.; Lee, K.W.; Lim, D.-S.; Lee, S. The Sulfated Polysaccharide Fucoidan Stimulates Osteogenic Differentiation of Human Adipose-Derived Stem Cells. Stem Cells Dev. 2012, 21, 2204–2211. [Google Scholar] [CrossRef]
  19. Lee, J.S.; Jin, G.H.; Yeo, M.G.; Jang, C.H.; Lee, H.; Kim, G.H. Fabrication of electrospun biocomposites comprising polycaprolactone/fucoidan for tissue regeneration. Carbohydr. Polym. 2012, 90, 181–188. [Google Scholar] [CrossRef]
  20. Huang, Y.-C.; Liu, T.-J. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Acta Biomater. 2012, 8, 1048–1056. [Google Scholar] [CrossRef]
  21. Lowe, B.; Venkatesan, J.; Anil, S.; Shim, M.S.; Kim, S.K. Preparation and characterization of chitosan-natural nanohydroxyapatite-fucoidan nanocomposites for bone tissue engineering. Int. J. Biol. Macromol. 2016, 93, 1479–1487. [Google Scholar] [CrossRef]
  22. Bhutani, U.; Laha, A.; Mitra, K.; Majumdar, S. Sodium alginate and gelatin hydrogels: Viscosity effect on hydrophobic drug release. Mater. Lett. 2016, 164, 76–79. [Google Scholar] [CrossRef]
  23. Voron’koa, N.G.; Derkacha, S.R.; Kuchinaa, Y.A.; Sokolana, N.I.; Kuranovaa, L.K.; Obluchinskaya, E.D. Influence of added gelatin on the rheological properties of a Fucus vesiculosus extract. Food Biosci. 2019, 29, 1–8. [Google Scholar] [CrossRef]
  24. Mou, C.; Yang, Y.; Bai, Y.; Yuan, P.; Wang, Y.; Zhang, L. Hyaluronic acid and polydopamine functionalized phase change nanoparticles for ultrasound imaging-guided photothermal-chemotherapy. J. Mater. Chem. B 2019, 7, 1246–1257. [Google Scholar] [CrossRef]
  25. Luo, C.; Liu, W.; Luo, B.; Tian, J.; Wen, W.; Liu, M.; Zhou, C. Antibacterial activity and cytocompatibility of chitooligosaccharide-modified polyurethane membrane via polydopamine adhesive layer. Carbohydr. Polym. 2017, 156, 235–243. [Google Scholar] [CrossRef]
  26. Ge, J.; Gu, K.; Sun, K.; Wang, X.; Yao, S.; Mo, X.; Long, S.; Lan, T.; Qin, C. Preparation and Swelling Behaviors of High-Strength Hemicellulose-g-Polydopamine Composite Hydrogels. Materials 2021, 14, 186. [Google Scholar] [CrossRef]
  27. Zhang, M.; Huang, Y.; Pan, W.; Tong, X.; Zeng, Q.; Su, T.; Qi, X.; Shen, J. Polydopamine-incorporated dextran hydrogel drug carrier with tailorable structure for wound healing. Carbohydr. Polym. 2021, 253, 117213. [Google Scholar] [CrossRef]
  28. Lee, M.; Kim, Y.; Ryu, J.H.; Kim, K.; Han, Y.-M.; Lee, H. Long-term, feeder-free maintenance of human embryonic stem cells by mussel-inspired adhesive heparin and collagen type I. Acta Biomater. 2016, 32, 138–148. [Google Scholar] [CrossRef]
  29. Wang, M.; Deng, Y.; Zhou, P.; Luo, Z.; Li, Q.; Xie, B.; Zhang, X.; Chen, T.; Pei, D.; Tang, Z.; et al. In Vitro Culture and Directed Osteogenic Differentiation of Human Pluripotent Stem Cells on Peptides-Decorated Two-Dimensional Microenvironment. ACS Appl. Mater. Interfaces 2015, 7, 4560–4572. [Google Scholar] [CrossRef]
  30. Li, Y.-M.; Wu, J.-Y.; Jiang, J.; Dong, S.-K.; Chen, Y.-S.; He, H.-Y.; Liu, C.-S.; Zhao, J.-Z. Chondroitin sulfate-polydopamine modified polyethylene terephthalate with extracellular matrix-mimetic immunoregulatory functions for osseointegration. J. Mater. Chem. B 2019, 7, 7756–7770. [Google Scholar] [CrossRef]
  31. Carnes, D.L.; Maeder, C.L.; Graves, D.T. Cells with Osteoblastic Phenotypes Can Be Explanted From Human Gingiva and Periodontal Ligament. J. Periodontol. 1997, 68, 701–707. [Google Scholar] [CrossRef]
  32. Cho, H.; Tarafder, S.; Fogge, M.; Kao, K.; Lee, C.H. Periodontal ligament stem/progenitor cells with protein-releasing scaffolds for cementum formation and integration on dentin surface. Connect. Tissue Res. 2016, 57, 488–495. [Google Scholar] [CrossRef] [PubMed]
  33. Kl, V.; Ryana, H.; Dalvi, P.J. Autologous periodontal stem cell assistance in periodontal regeneration technique (SAI-PRT) in the treatment of periodontal intrabony defects: A case report with one-year follow-up. J. Dent. Res. Dent. Clin. Dent. Prospect. 2017, 11, 123–126. [Google Scholar] [CrossRef] [PubMed]
  34. Lee, J.-S.; Kim, E.; Han, S.; Kang, K.L.; Heo, J.S. Evaluating the oxysterol combination of 22(S)-hydroxycholesterol and 20(S)-hydroxycholesterol in periodontal regeneration using periodontal ligament stem cells and alveolar bone healing models. Stem Cell Res. Ther. 2017, 8, 276. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Feng, F.; Akiyama, K.; Liu, Y.; Yamaza, T.; Wang, T.-M.; Chen, J.-H.; Wang, B.B.; Huang, G.T.-J.; Wang, S.; Shi, S. Utility of PDL progenitors for in vivo tissue regeneration: A report of 3 cases. Oral Dis. 2010, 16, 20–28. [Google Scholar] [CrossRef]
  36. Eleuterio, E.; Trubiani, O.; Sulpizio, M.; Di Giuseppe, F.; Pierdomenico, L.; Marchisio, M.; Giancola, R.; Giammaria, G.; Miscia, S. Proteome of human stem cells from periodontal ligament and dental pulp. PLoS ONE 2013, 8, e71101. [Google Scholar] [CrossRef] [Green Version]
  37. Manivasagan, P.; Hoang, G.; Moorthy, M.S.; Mondal, S.; Doan, V.H.M.; Kim, H.; Phan, T.T.V.; Nguyen, T.P.; Oh, J. Chitosan/fucoidan multilayer coating of gold nanorods as highly efficient near-infrared photothermal agents for cancer therapy. Carbohydr. Polym. 2019, 211, 360–369. [Google Scholar] [CrossRef]
  38. Kim, Y.W.; Baek, S.-H.; Lee, S.-H.; Kim, T.-H.; Kim, S.-Y. Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling. Int. J. Mol. Sci. 2014, 15, 18840–18855. [Google Scholar] [CrossRef] [Green Version]
  39. Venkatesan, J.; Bhatnagar, I.; Kim, S.K. Chitosan-alginate biocomposite containing fucoidan for bone tissue engineering. Mar. Drugs. 2014, 12, 300–316. [Google Scholar] [CrossRef]
  40. Wang, F.; Schmidt, H.; Pavleska, D.; Wermann, T.; Seekamp, A.; Fuchs, S. Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bone Regeneration and Osteosarcoma via Reduction of VEGF and SDF-1. Mar. Drugs 2017, 15, 186. [Google Scholar] [CrossRef] [Green Version]
  41. Lu, H.-T.; Lu, T.-W.; Chen, C.-H.; Mi, F.-L. Development of genipin-crosslinked and fucoidan-adsorbed nano-hydroxyapatite/hydroxypropyl chitosan composite scaffolds for bone tissue engineering. Int. J. Biol. Macromol. 2019, 128, 973–984. [Google Scholar] [CrossRef]
  42. Case, L.B.; Waterman, C.M. Integration of actin dynamics and cell adhesion by a three-dimensional, mechanosensitive molecular clutch. Nat. Cell Biol. 2015, 17, 955–963. [Google Scholar] [CrossRef]
  43. Schwarz, U.S.; Gardel, M.L. United we stand–integrating the actin cytoskeleton and cell–matrix adhesions in cellular mechanotransduction. J. Cell Sci. 2012, 125, 3051–3060. [Google Scholar] [CrossRef] [Green Version]
  44. Zhao, Y.; Sun, Q.; Wang, S.; Huo, B. Spreading Shape and Area Regulate the Osteogenesis of Mesenchymal Stem Cells. Tissue Eng. Regen. Med. 2019, 16, 573–583. [Google Scholar] [CrossRef]
  45. Lu, J.; Fan, Y.; Gong, X.; Zhou, X.; Yi, C.; Zhang, Y.; Pan, J. The Lineage Specification of Mesenchymal Stem Cells Is Directed by the Rate of Fluid Shear Stress. J. Cell. Physiol. 2016, 231, 1752–1760. [Google Scholar] [CrossRef]
  46. Vishavkarma, R.; Raghavan, S.; Kuyyamudi, C.; Majumder, A.; Dhawan, J.; Pullarkat, P.A. Role of Actin Filaments in Correlating Nuclear Shape and Cell Spreading. PLoS ONE 2014, 9, e107895. [Google Scholar] [CrossRef] [Green Version]
  47. Han, N.; Jia, L.; Guo, L.; Su, Y.; Luo, Z.; Du, J.; Mei, S.; Liu, Y. Balanced oral pathogenic bacteria and probiotics promoted wound healing via maintaining mesenchymal stem cell homeostasis. Stem Cell Res. Ther. 2020, 11, 1–12. [Google Scholar] [CrossRef]
  48. Mun, H.; Jeon, T.J. Regulation of actin cytoskeleton by Rap1 binding to RacGEF1. Mol. Cells 2012, 34, 71–76. [Google Scholar] [CrossRef] [Green Version]
  49. Hoelzle, M.K.; Svitkina, T. The cytoskeletal mechanisms of cell–cell junction formation in endothelial cells. Mol. Biol. Cell 2012, 23, 310–323. [Google Scholar] [CrossRef]
  50. Wu, Y.; Zhou, J.; Li, Y.; Zhou, Y.; Cui, Y.; Yang, G.; Hong, Y. Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling. PLoS ONE 2015, 10, e0143777. [Google Scholar] [CrossRef]
  51. Pan, B.L.; Tong, Z.W.; Li, S.D.; Wu, L.; Liao, J.L.; Yang, Y.X.; Li, H.H.; Dai, Y.J.; Li, J.E.; Pan, L. Decreased microRNA-182-5p helps alendronate promote osteoblast proliferation and differentiation in osteoporosis via the Rap1/MAPK pathway. Biosci. Rep. 2018, 38, BSR20180696. [Google Scholar] [CrossRef] [Green Version]
  52. Xu, D.; Wan, Y.; Li, Z.; Wang, C.; Zou, Q.; Du, C.; Wang, Y. Tailorable hierarchical structures of biomimetic hydroxyapatite micro/nano particles promoting endocytosis and osteogenic differentiation of stem cells. Biomater. Sci. 2020, 8, 3286–3300. [Google Scholar] [CrossRef] [PubMed]
  53. Balla, T. Phosphoinositides: Tiny Lipids with Giant Impact on Cell Regulation. Physiol. Rev. 2013, 93, 1019–1137. [Google Scholar] [CrossRef] [PubMed]
  54. Hemmings, B.A.; Restuccia, D.F. Pi3k-pkb/akt pathway. Cold Spring Harb. Perspect. Biol. 2012, 4, a011189. [Google Scholar]
  55. Mao, Y.S.; Yin, H.L. Regulation of the actin cytoskeleton by phosphatidylinositol 4-phosphate 5 kinases. Pflügers Arch. J. Physiol. 2007, 455, 5–18. [Google Scholar] [CrossRef]
  56. Van den Bout, I.; Divecha, N. PIP5K-driven PtdIns(4,5)P2 synthesis: Regulation and cellular functions. J. Cell Sci. 2009, 122, 3837–3850. [Google Scholar] [CrossRef]
  57. Zhao, X.; Cui, P.; Hu, G.; Wang, C.; Jiang, L.; Zhao, J.; Xu, J.; Zhang, X. PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. J. Mol. Cell Biol. 2020, 12, 55–70. [Google Scholar] [CrossRef] [Green Version]
  58. Gong, W.; Zhang, N.; Cheng, G. Rehmannia glutinosa Libosch extracts prevent bone loss and architectural deterioration and enhance osteoblastic bone formation by regulating the IGF-1/PI3K/mTOR pathway in streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2019, 20, 3964. [Google Scholar] [CrossRef] [Green Version]
  59. Park, Y.-K.; Heo, S.-J.; Koak, J.-Y.; Park, G.-S.; Cho, T.-J.; Kim, S.-K.; Cho, J. Characterization and Differentiation of Circulating Blood Mesenchymal Stem Cells and the Role of Phosphatidylinositol 3-Kinase in Modulating the Adhesion. Int. J. Stem Cells 2019, 12, 265–278. [Google Scholar] [CrossRef]
  60. Lang, L.; Hou, Y.; Chen, Y.; Tu, G.; Tao, J.; Yang, D.; Xi, L.; Fu, L.; Sun, K.; Yin, J.; et al. ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion. Cell. Physiol. Biochem. 2018, 51, 2972–2988. [Google Scholar] [CrossRef]
  61. Richard, P.; Feng, S.; Tsai, Y.-L.; Li, W.; Rinchetti, P.; Muhith, U.; Irizarry-Cole, J.; Stolz, K.; Sanz, L.A.; Hartono, S.; et al. SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation. Autophagy 2021, 17, 1889–1906. [Google Scholar] [CrossRef]
  62. Shim, N.Y.; Ryu, J.; Heo, J.S. Osteoinductive function of fucoidan on periodontal ligament stem cells: Role of PI3K/Akt and Wnt/β-catenin signaling pathways. Oral Dis. 2021. [Google Scholar] [CrossRef]
  63. Shim, N.; Heo, J. Performance of the Polydopamine-Graphene Oxide Composite Substrate in the Osteogenic Differentiation of Mouse Embryonic Stem Cells. Int. J. Mol. Sci. 2021, 22, 7323. [Google Scholar] [CrossRef]
  64. An, S.Y.; Lee, H.J.; Lee, S.C.; Heo, J.S. Supplement of nitric oxide through calcium carbonate-based nanoparticles contributes osteogenic differentiation of mouse embryonic stem cells. Tissue Cell 2020, 66, 101390. [Google Scholar] [CrossRef]
  65. Langmead, B.; Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9, 357–359. [Google Scholar] [CrossRef] [Green Version]
  66. Quinlan, A.R.; Hall, I.M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26, 841–842. [Google Scholar] [CrossRef] [Green Version]
  67. Gentleman, R.C.; Carey, V.J.; Bates, D.M.; Bolstad, B.; Dettling, M.; Dudoit, S.; Ellis, B.; Gautier, L.; Ge, Y.; Gentry, J.; et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004, 5, R80. [Google Scholar] [CrossRef] [Green Version]
Marinedrugs 20 00181 g001 550
Figure 1. Surface morphology of fucoidan/PDA composite. (A) Scanning electron microscopy images of the PT surface (control) and fucoidan/PDA (1 µg/mL + 1 mg/mL)-coated surfaces at ×10 magnification. (B) Relative atomic composition of each surface. Cells were cultured on the fucoidan/PDA composite (PDA with 1 mg/mL and variable fucoidan concentration with 0.5 or 1 µg/mL) for 4, 7, and 14 days. (C) ALP activity, (D) [Ca2+]i and (E) Alizarin Red S staining were assessed (magnification 200×). Values are presented as means ± SD (n = 4, * p < 0.05 vs. the control value at each time point).
Figure 1. Surface morphology of fucoidan/PDA composite. (A) Scanning electron microscopy images of the PT surface (control) and fucoidan/PDA (1 µg/mL + 1 mg/mL)-coated surfaces at ×10 magnification. (B) Relative atomic composition of each surface. Cells were cultured on the fucoidan/PDA composite (PDA with 1 mg/mL and variable fucoidan concentration with 0.5 or 1 µg/mL) for 4, 7, and 14 days. (C) ALP activity, (D) [Ca2+]i and (E) Alizarin Red S staining were assessed (magnification 200×). Values are presented as means ± SD (n = 4, * p < 0.05 vs. the control value at each time point).
Marinedrugs 20 00181 g001
Marinedrugs 20 00181 g002 550
Figure 2. Effect of fucoidan/PDA composite on osteogenic markers. (A–E) The mRNA expression of RUNX2, OPN, COLI, OSX, and OCN was evaluated by real-time RT-PCR after 7-day osteogenic induction. (F) Protein levels of OCN (5.5 kDa) and RUNX2 (55 kDa) were analyzed by Western blot analysis. The values are denoted as means ± SD (n = 3, * p < 0.05).
Figure 2. Effect of fucoidan/PDA composite on osteogenic markers. (A–E) The mRNA expression of RUNX2, OPN, COLI, OSX, and OCN was evaluated by real-time RT-PCR after 7-day osteogenic induction. (F) Protein levels of OCN (5.5 kDa) and RUNX2 (55 kDa) were analyzed by Western blot analysis. The values are denoted as means ± SD (n = 3, * p < 0.05).
Marinedrugs 20 00181 g002
Marinedrugs 20 00181 g003 550
Figure 3. RNA sequencing analysis of PDLSCs cultured on the fucoidan/PDA composite. (A) Numbers of upregulated and downregulated genes in cells on fucoidan/PDA compared to those in control groups with at least a twofold change in expression level. Hierarchical clustering of significant DEGs. Red represents upregulation; blue represents downregulation. The top 10 enriched gene ontology terms in the (B) biological process and (C) molecular function categories from DAVID gene ontology term analysis for DEGs. (D) The expressions of three up and three down genes (randomly selected) were evaluated by real-time RT-PCR to validate the RNA-Seq data. The values are presented as means ± SD of three independent experiments.
Figure 3. RNA sequencing analysis of PDLSCs cultured on the fucoidan/PDA composite. (A) Numbers of upregulated and downregulated genes in cells on fucoidan/PDA compared to those in control groups with at least a twofold change in expression level. Hierarchical clustering of significant DEGs. Red represents upregulation; blue represents downregulation. The top 10 enriched gene ontology terms in the (B) biological process and (C) molecular function categories from DAVID gene ontology term analysis for DEGs. (D) The expressions of three up and three down genes (randomly selected) were evaluated by real-time RT-PCR to validate the RNA-Seq data. The values are presented as means ± SD of three independent experiments.
Marinedrugs 20 00181 g003
Marinedrugs 20 00181 g004 550
Figure 4. KEGG pathway analysis: regulation of actin cytoskeleton. The red stars represent key player genes.
Figure 4. KEGG pathway analysis: regulation of actin cytoskeleton. The red stars represent key player genes.
Marinedrugs 20 00181 g004
Marinedrugs 20 00181 g005 550
Figure 5. KEGG pathway analysis: Rap1 signaling pathway.
Figure 5. KEGG pathway analysis: Rap1 signaling pathway.
Marinedrugs 20 00181 g005
Marinedrugs 20 00181 g006 550
Figure 6. KEGG pathway analysis: phosphatidylinositol signaling system.
Figure 6. KEGG pathway analysis: phosphatidylinositol signaling system.
Marinedrugs 20 00181 g006
Marinedrugs 20 00181 g007 550
Figure 7. The protein–protein interaction network of DEGs was analyzed based on the STRING database. Each node depicts a protein. The thickness of lines was based on the strength of data support.
Figure 7. The protein–protein interaction network of DEGs was analyzed based on the STRING database. Each node depicts a protein. The thickness of lines was based on the strength of data support.
Marinedrugs 20 00181 g007
Marinedrugs 20 00181 g008 550
Figure 8. Top hubs of networks. (A) Top hub proteins with the highest number of interactions. (B) KRAS and ATM hub networks. KRAS and ATM represent hub proteins with the highest number of predicted protein interactions, numbering 21.
Figure 8. Top hubs of networks. (A) Top hub proteins with the highest number of interactions. (B) KRAS and ATM hub networks. KRAS and ATM represent hub proteins with the highest number of predicted protein interactions, numbering 21.
Marinedrugs 20 00181 g008
Table
Table 1. Top 10 enriched KEGG pathways analysis. Potential genes (n = 348) were imported into DAVID tools. Categories are based on the KEGG database.
Table 1. Top 10 enriched KEGG pathways analysis. Potential genes (n = 348) were imported into DAVID tools. Categories are based on the KEGG database.
CategoryTermCountGenes
KEGG_PATHWAYPathways in cancer11RB1, PDGFRA, FGF7, APC, MSH1, PIK3CA, ROCK2, GNB4, TRAF2, KRAS
KEGG_PATHWAYRegulation of actin cytoskeleton9APC, KRAS, ROCK2, ENAH, FGF7, PIK3CA, PDGFRA, PPP1CB, PPP1R12A
KEGG_PATHWAYRap1 signaling pathway7KRAS, RAPGEF6, FGF7, MAGI3, PIK3CA, PLCE1, PDGFRA
KEGG_PATHWAYOxytocin signaling pathway6PPP1CB, OXTR, PPP1R12A, ROCK2, KRAS
KEGG_PATHWAYInositol phosphate metabolism5INPP4B, SYNJ1, PIK3CA, IMPA1, PLCE1
KEGG_PATHWAYMelanoma5RB1, PDGFRA, FGF7, PIKC3A, KRAS
KEGG_PATHWAYPhosphatidylinositol signaling system5INPP4B, SYNJ1, PIK3CA, IMPA1, PLCE1
KEGG_PATHWAYMineral absorption4HMOX1, TRPM7, CLCN2, FTL
KEGG_PATHWAYColorectal cancer4APC, MSH2, PIK3CA, KRAS
KEGG_PATHWAYGlioma4RB1, PDGFRA, PIK3CA, KRAS
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kwack, K.H.; Ji, J.Y.; Park, B.; Heo, J.S. Fucoidan (Undaria pinnatifida)/Polydopamine Composite-Modified Surface Promotes Osteogenic Potential of Periodontal Ligament Stem Cells. Mar. Drugs 2022, 20, 181. https://doi.org/10.3390/md20030181

AMA Style

Kwack KH, Ji JY, Park B, Heo JS. Fucoidan (Undaria pinnatifida)/Polydopamine Composite-Modified Surface Promotes Osteogenic Potential of Periodontal Ligament Stem Cells. Marine Drugs. 2022; 20(3):181. https://doi.org/10.3390/md20030181

Chicago/Turabian Style

Kwack, Kyu Hwan, Ju Young Ji, Borami Park, and Jung Sun Heo. 2022. "Fucoidan (Undaria pinnatifida)/Polydopamine Composite-Modified Surface Promotes Osteogenic Potential of Periodontal Ligament Stem Cells" Marine Drugs 20, no. 3: 181. https://doi.org/10.3390/md20030181

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop